<TEXT>&#2;<DATELINE>2017-12-01</DATELINE><TITLE>Impact of respiratory virus molecular testing on antibiotic utilization in community-acquired pneumonia</TITLE><BODY>We compared the clinical characteristics and antibiotic therapy of community-acquired pneumonia patients who were positive on a respiratory virus molecular test (polymerase chain reaction) with those who were negative. We found that respiratory virus molecular polymerase chain reaction testing has a minimal impact on reducing antibiotic utilization among viral pneumonia patients.&#3;</BODY></TEXT>